🇺🇸 FDA
Pipeline program

SUBOXONE

RB-US-13-0001

Phase 3 small_molecule completed

Quick answer

SUBOXONE for Opioid Dependence is a Phase 3 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Opioid Dependence
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials